The quantitative reduction by acute-dose warfarin of venous thrombosis in normal and hyperthrombotic rats

Thrombosis Research
S M Lavelle, M M Iomhair

Abstract

Warfarin was tested for its relative ability to reduce thrombosis in two series of rats. In one series both the warfarin and control animals were made hyperthrombotic by an infusion of ellagic acid just before thrombosis was measured. In the second series (termed normothrombotic) no thrombotic stimulant was given. In all, 179 test and 109 control animals were used. Warfarin was given in varying doses to the test animals. Ellagic acid was administered as a single standard dose. At operation, two test animals and one control of similar weight were operated on concurrently. Thrombosis was measured by the weight of thrombus occurring on a standard 2 cm intravenous platinum wire in one hour. In optimum dose, warfarin reduced thrombus formation by 74% in the unstimulated series and by 83% in the hyperthrombotic one, when the mean factor II levels were 18% and 19% respectively. The residual thrombus under warfarin treatment was, however, greater in the hyperthrombotic than in the unstimulated animals at all levels of factor II. Best correlation of thrombus weight was with factor II in unstimulated animals.

References

Nov 1, 1978·British Journal of Haematology·G J Stewart
Jun 27, 1991·The New England Journal of Medicine·J Hirsh
Jan 1, 1989·Journal of Clinical Epidemiology·D B PetittiK L Melmon
Jun 1, 1985·Annals of Internal Medicine·A I Schafer
May 8, 1965·Nature·S NordströmM Blombäck
Jan 1, 1994·Seminars in Thrombosis and Hemostasis·R L Bick, M Pegram
Dec 1, 1957·Proceedings of the Society for Experimental Biology and Medicine·H S SISER BECKER
Jan 1, 1951·Scandinavian Journal of Clinical and Laboratory Investigation·P A OWREN, K AAS
Aug 31, 2007·Pediatric Blood & Cancer·Roderick SkinnerUNKNOWN Paediatric Oncology Nursing Forum (PONF) Supportive Care Group
Nov 17, 1962·Canadian Medical Association Journal

❮ Previous
Next ❯

Citations

Dec 30, 1998·Irish Journal of Medical Science·S M Lavelle, M MacIomhair

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.